AUPH Aurinia Pharmaceuticals Inc

$8.18

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-03-31
Expected on May 01, 2025
Report Time: Unknown Release Time
The Whisper Number
$0.10
Consensus Estimate: $0.10
Revenue Estimate: $61.11M

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.

Website: https://www.auriniapharma.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1600620
Address
#140, 14315 - 118 AVENUE, EDMONTON, AB, CANADA
Valuation
Market Cap
$1.06B
P/E Ratio
193.75
PEG Ratio
0.00
Price to Book
2.82
Performance
EPS
$0.04
Dividend Yield
—
Profit Margin
2.45%
ROE
1.52%
Technicals
50D MA
$8.02
200D MA
$7.50
52W High
$10.67
52W Low
$4.77
Fundamentals
Shares Outstanding
137M
Target Price
$9.83
Beta
1.22

AUPH EPS Estimates vs Actual

● Estimated
● Actual

AUPH News & Sentiment

Apr 24, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics
Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics are part of the Zacks Industry Outlook article.
Apr 23, 2025 • Zacks Commentary SOMEWHAT-BULLISH
5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms
Innovation is at its peak for the Zacks Medical-Drugs industry. AUPH, HRTX, ESPR, PYXS and PSTV may prove to be good additions to one's portfolio.
Mar 20, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Strength Seen in Xeris Biopharma ( XERS ) : Can Its 5.6% Jump Turn into More Strength?
Xeris Biopharma (XERS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Mar 04, 2025 • Zacks Commentary NEUTRAL
Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals ( AUPH ) Stock?
Investors need to pay close attention to Aurinia Pharmaceuticals (AUPH) stock based on the movements in the options market lately.
Feb 27, 2025 • Benzinga SOMEWHAT-BULLISH
Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations - Aurinia Pharmaceuticals ( NASDAQ:AUPH )
Aurinia posted Q4 earnings of 1 cent per share, beating the expected loss of 2 cents; Sales spiked 33% to $59.9M, in line with estimates. LUPKYNIS net sales reached $57.6M, up 36% YoY, while 2024 total net product sales hit $216.2M, meeting management's guidance.
Feb 27, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Aurinia Pharmaceuticals ( AUPH ) Beats Q4 Earnings and Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of 200% and 0.25%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Sentiment Snapshot

Average Sentiment Score:

0.177
50 articles with scored sentiment

Overall Sentiment:

Bullish

AUPH Reported Earnings

Feb 13, 2025
Dec 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.02
  • Whisper: —
  • Surprise %: 162.5%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.09 Surprise
  • Reported EPS: $0.10
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: 900.0%
Aug 01, 2024
Jun 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.01
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: 0.0%
May 02, 2024
Mar 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.14
  • Whisper: —
  • Surprise %: 78.6%
Feb 15, 2024
Dec 31, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $-0.19
  • Estimate: $-0.16
  • Whisper: —
  • Surprise %: -18.8%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.08 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.17
  • Whisper: —
  • Surprise %: 47.1%
Aug 03, 2023
Jun 30, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $-0.08
  • Estimate: $-0.18
  • Whisper: —
  • Surprise %: 55.6%
May 04, 2023
Mar 31, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $-0.18
  • Estimate: $-0.22
  • Whisper: —
  • Surprise %: 18.2%
Feb 28, 2023
Dec 31, 2022 (Pre market)
0.09 Surprise
  • Reported EPS: $-0.18
  • Estimate: $-0.27
  • Whisper: —
  • Surprise %: 33.3%

Financials